{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:14:06Z","timestamp":1766870046433,"version":"3.44.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bulcan.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T07:24:07Z","timestamp":1666682647000},"page":"S13-S29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["Conduite \u00e0 tenir devant une pr\u00e9disposition g\u00e9n\u00e9tique aux h\u00e9mopathies malignes chez un patient candidat \u00e0 l\u2019allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques (CSH)\u00a0: recommandations de la SFGM-TC"],"prefix":"10.1016","volume":"110","author":[{"given":"Val\u00e9rie","family":"Coiteux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laur\u00e8ne","family":"Fenwarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Duployez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malika","family":"Ainaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Borel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Polomeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Chalandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2022.09.002_bib0660","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1097\/HS9.0000000000000321","article-title":"Nordic guidelines for germline predisposition to myeloid neoplasms in adults: recommendations for genetic diagnosis, clinical management and follow-up","volume":"3","author":"Baliakas","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0665","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016\u00a0revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0670","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2\u00a0causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0675","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa041331","article-title":"Mutation of CEBPA in familial acute myeloid leukemia","volume":"351","author":"Smith","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0680","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajhg.2016.04.009","article-title":"Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L","volume":"98","author":"Chen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0685","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.913","article-title":"Heritable GATA2\u00a0mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia","volume":"43","author":"Hahn","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0690","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41467-019-09198-7","article-title":"Impact of constitutional TET2\u00a0haploinsufficiency on molecular and clinical phenotype in humans","volume":"10","author":"Kaasinen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0695","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S1470-2045(15)00369-1","article-title":"Germline genetic variation in ETV6\u00a0and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study","volume":"16","author":"Moriyama","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0700","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9\u00a0mutations cause a novel multisystem disorder, MIRAGE syndrome and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0705","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1182\/blood-2011-02-336537","article-title":"Mutations in ANKRD26\u00a0are responsible for a frequent form of inherited thrombocytopenia: analysis of 78\u00a0patients from 21\u00a0families","volume":"117","author":"Noris","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0710","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","article-title":"Inherited and somatic defects in DDX41\u00a0in myeloid neoplasms","volume":"27","author":"Polprasert","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0715","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3380","article-title":"Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies","volume":"47","author":"Saliba","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0720","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ng.2754","article-title":"A recurrent germline PAX5\u00a0mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"45","author":"Shah","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0725","doi-asserted-by":"crossref","first-page":"937e8","DOI":"10.1016\/j.ccell.2018.03.021","article-title":"Germline genetic IKZF1\u00a0variation and predisposition to childhood acute lymphoblastic leukemia","volume":"33","author":"Churchman","year":"2018","journal-title":"Cancer Cell"},{"year":"2020","series-title":"Fanconi anemia: guidelines for diagnosis and management fund FAR","key":"10.1016\/j.bulcan.2022.09.002_bib0730"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0735","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2011.06349.x","article-title":"Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome","volume":"1242","author":"Dror","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0740","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2141.2008.07269.x","article-title":"Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference","volume":"142","author":"Vlachos","year":"2008","journal-title":"Br J Haematol"},{"year":"2015","series-title":"Dyskeratosis congenita and telomere biology disorders: diagnosis and management guidelines","author":"Savage","key":"10.1016\/j.bulcan.2022.09.002_bib0745"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0750","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fgene.2018.00624","article-title":"A systematic review of the psychological implications of genetic testing: a comparative analysis among cardiovascular, neurodegenerative and cancer diseases","volume":"9","author":"Oliveri","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0755","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1002\/hast.1021","article-title":"What is the psychosocial impact of providing genetic and genomic health information to individuals? An overview of systematic reviews","volume":"49","author":"Wade","year":"2019","journal-title":"Hastings Cent Rep"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0760","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"How we harmonize HSCT clinical practices among the SFGM-TC centers","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0765","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2016-05-670240","article-title":"How I diagnose and manage individuals at risk for inherited myeloid malignancies","volume":"128","author":"University of Chicago Hematopoietic Malignancies Cancer Risk Team","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0770","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2017-02-735290","article-title":"Genetic predisposition to hematologic malignancies: management and surveillance","volume":"130","author":"Godley","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0775","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","article-title":"Natural history of GATA2\u00a0deficiency in a survey of 79\u00a0French and Belgian patients","volume":"103","author":"Donadieu","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0780","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.278762","article-title":"The RUNX1\u00a0Database (RUNX1db): establishment of an expert curated RUNX1\u00a0registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy","author":"Homan","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0785","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood.2019000909","article-title":"Germline DDX41\u00a0mutations define a significant entity within adult MDS\/AML patients","volume":"134","author":"S\u00e9bert","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0790","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3324\/haematol.2020.248872","article-title":"Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02\u00a0trial","volume":"106","author":"Fenwarth","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0795","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1097\/HS9.0000000000000203","article-title":"Germline RUNX1\u00a0intragenic deletion: implications for accurate diagnosis of FPD\/AML","volume":"3","author":"Duployez","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0800","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Jongen-Lavrencic","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0805","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41375-019-0675-6","article-title":"Familial myeloid malignancies with germline TET2\u00a0mutation","volume":"34","author":"Duployez","year":"2020","journal-title":"Leukemia"},{"year":"2021","series-title":"Code de la Sant\u00e9 Publique - Examen des caract\u00e9ristiques g\u00e9n\u00e9tiques d\u2019une personne et identification par empreintes g\u00e9n\u00e9tiques \u00e0 des fins m\u00e9dicales - Article L1130-2","key":"10.1016\/j.bulcan.2022.09.002_bib0810"},{"year":"2008","series-title":"Code de la Sant\u00e9 Publique - Examen des caract\u00e9ristiques g\u00e9n\u00e9tiques d\u2019une personne et identification par empreintes g\u00e9n\u00e9tiques \u00e0 des fins m\u00e9dicales - Article R1131-4","key":"10.1016\/j.bulcan.2022.09.002_bib0815"},{"year":"2013","series-title":"Code de la Sant\u00e9 Publique - Examen des caract\u00e9ristiques g\u00e9n\u00e9tiques d\u2019une personne et identification par empreintes g\u00e9n\u00e9tiques \u00e0 des fins m\u00e9dicales - Article R1131-20-1","key":"10.1016\/j.bulcan.2022.09.002_bib0820"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0825","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.ejhg.5201883","article-title":"Process and outcome in communication of genetic information within families: a systematic review","volume":"15","author":"Gaff","year":"2007","journal-title":"Eur J Hum Genet EJHG"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0830","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3166\/pson-2021-0170","article-title":"La m\u00e9decine pr\u00e9dictive \u00e0 l\u2019\u00e9preuve de l\u2019oncoh\u00e9matologie: r\u00e9flexions \u00e0 partir de la clinique","volume":"15","author":"Polomeni","year":"2021","journal-title":"Psycho-Oncol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0835","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017\u00a0ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0840","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0845","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.seminhematol.2017.05.002","article-title":"GATA2\u00a0deficiency and related myeloid neoplasms","volume":"54","author":"Wlodarski","year":"2017","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0850","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1200\/PO.20.00387","article-title":"Inherited susceptibility to hematopoietic malignancies in the era of precision oncology","author":"Roloff","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0855","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.seminhematol.2017.04.005","article-title":"ETV6\u00a0in hematopoiesis and leukemia predisposition","volume":"54","author":"Hock","year":"2017","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0860","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.bulcan.2019.02.006","article-title":"Suivi des donneurs apparent\u00e9s: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","volume":"107","author":"Polomeni","year":"2020","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0865","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.2019000937","article-title":"Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)","volume":"136","author":"Brown","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0870","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbmt.2020.02.015","article-title":"Comparison of outcomes of myeloablative allogeneic stem cell transplantation for pediatric patients with bone marrow failure, myelodysplastic syndrome and acute myeloid leukemia with and without germline GATA2\u00a0mutations","volume":"26","author":"Hofmann","year":"2020","journal-title":"Biol Blood Marrow Transplant J"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0875","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.236","article-title":"Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia","volume":"30","author":"Antony-Debr\u00e9","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0880","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","article-title":"RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0885","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ejh.12981","article-title":"Detection of a new heterozygous germline ETV6\u00a0mutation in a case with hyperdiploid acute lymphoblastic leukemia","volume":"100","author":"Duployez","year":"2018","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0890","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/blood.2019852418","article-title":"ETV6-related thrombocytopenia and leukemia predisposition","volume":"134","author":"Di Paola","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0895","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3324\/haematol.2015.130799","article-title":"Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large family","volume":"101","author":"Pathak","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0900","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2015-05-647172","article-title":"Disease evolution and outcomes in familial AML with germline CEBPA mutations","volume":"126","author":"Tawana","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0905","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1182\/blood-2015-10-676098","article-title":"Novel germ line DDX41\u00a0mutations define families with a lower age of MDS\/AML onset and lymphoid malignancies","volume":"127","author":"Lewinsohn","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0910","article-title":"Molecular and clinical features of myeloid neoplasms with somatic DDX41\u00a0mutations","author":"Qu","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0915","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/blood.2019000909","article-title":"Germline DDX41\u00a0mutations define a significant entity within adult MDS\/AML patients","volume":"134","author":"S\u00e9bert","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0920","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/s41375-019-0675-6","article-title":"Familial myeloid malignancies with germline TET2\u00a0mutation","volume":"34","author":"Duployez","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0925","first-page":"1","article-title":"Germline ATG2B\/GSKIP-containing 14q32\u00a0duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms","author":"Pegliasco","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0930","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.2020005756","article-title":"Germline PAX5\u00a0mutation predisposes to familial B-cell precursor acute lymphoblastic leukemia","volume":"137","author":"Duployez","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0935","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3324\/haematol.2017.181909","article-title":"Natural history of GATA2\u00a0deficiency in a survey of 79\u00a0French and Belgian patients","volume":"103","author":"Donadieu","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0940","doi-asserted-by":"crossref","first-page":"e121086","DOI":"10.1172\/jci.insight.121086","article-title":"Germline SAMD9\u00a0and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes","volume":"3","author":"Wong","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0945","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1182\/blood-2008-05-156745","article-title":"Five new pedigrees with inherited RUNX1\u00a0mutations causing familial platelet disorder with propensity to myeloid malignancy","volume":"112","author":"Owen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1042819031000139611","article-title":"Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia","volume":"45","author":"Ganly","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0955","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.leukres.2009.07.037","article-title":"Insights into familial platelet disorder with propensity to myeloid malignancy (FPD\/AML)","volume":"34","author":"Owen","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0960","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1182\/blood.V65.3.557.557","article-title":"Studies of a familial platelet disorder","volume":"65","author":"Dowton","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0965","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1182\/blood.V92.7.2600","article-title":"Evidence for genetic homogeneity in a familial platelet disorder with predisposition to acute myelogenous leukemia (FPD\/AML)","volume":"92","author":"Arepally","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0970","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2141.1991.tb04529.x","article-title":"Inherited platelet-storage pool deficiency associated with a high incidence of acute myeloid leukaemia","volume":"79","author":"Gerrard","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0975","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI115099","article-title":"Decreased content and surface expression of alpha-granule membrane protein GMP-140\u00a0in one of two types of platelet alpha delta storage pool deficiency","volume":"87","author":"Lages","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0980","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/leu.2012.79","article-title":"Elucidation of a novel pathogenomic mechanism using genome-wide long mate-pair sequencing of a congenital t(16;21) in a series of three RUNX1-mutated FPD\/AML pedigrees","volume":"26","author":"Buijs","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0985","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1046\/j.1365-2141.2002.03512.x","article-title":"A novel inherited mutation of the transcription factor RUNX1\u00a0causes thrombocytopenia and may predispose to acute myeloid leukaemia","volume":"117","author":"Walker","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0990","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1182\/blood.2019003357","article-title":"High frequency of germline RUNX1\u00a0mutations in patients with RUNX1-mutated AML","volume":"135","author":"Simon","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0995","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-016-0432-0","article-title":"Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1\u00a0mutations from the French network on inherited platelet disorders","volume":"11","author":"Latger-Cannard","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1000","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4236\/ijcm.2012.37110","article-title":"Hereditary leukemia due to rare RUNX1c splice variant (L472X) presents with eczematous phenotype","volume":"3","author":"Sorrell","year":"2012","journal-title":"Int J Clin Med"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1005","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2008-01-135970","article-title":"Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q","volume":"112","author":"Shinawi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1010","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood-2013-04-499319","article-title":"ANKRD26-related thrombocytopenia and myeloid malignancies","volume":"122","author":"Noris","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-016-0382-y","article-title":"5\u2032UTR point substitutions and N-terminal truncating mutations of ANKRD26\u00a0in acute myeloid leukemia","volume":"10","author":"Marconi","year":"2017","journal-title":"J Hematol Oncol J"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1020","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI71861","article-title":"Thrombocytopenia-associated mutations in the ANKRD26\u00a0regulatory region induce MAPK hyperactivation","volume":"124","author":"Bluteau","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1025","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3324\/haematol.2016.147496","article-title":"Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia","volume":"101","author":"Melazzini","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6\u00a0are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1035","doi-asserted-by":"crossref","first-page":"21719","DOI":"10.1073\/pnas.1006981107","article-title":"Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia","volume":"107","author":"Paulsson","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1040","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/bloodadvances.2018030635","article-title":"Germline deletion of ETV6\u00a0in familial acute lymphoblastic leukemia","volume":"3","author":"Rampersaud","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1045","doi-asserted-by":"crossref","first-page":"e1005262","DOI":"10.1371\/journal.pgen.1005262","article-title":"Germline ETV6\u00a0mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia","volume":"11","author":"Topka","year":"2015","journal-title":"PLOS Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germline ETV6\u00a0mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3324\/haematol.2016.147694","article-title":"Germline variants in ETV6\u00a0underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors","volume":"102","author":"Poggi","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1060","first-page":"1","article-title":"Functional analysis of germline ETV6\u00a0W380R mutation causing inherited thrombocytopenia and secondary acute lymphoblastic leukemia or essential thrombocythemia","author":"Kozubik","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1065","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/10428194.2017.1359742","article-title":"ETV6\u00a0and NOTCH1\u00a0germline variants in adult acute leukemia","volume":"59","author":"Dirse","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2141.2010.08204.x","article-title":"Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3\u00a0and CDX2\u00a0genes","volume":"150","author":"Carmichael","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1075","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.3324\/haematol.2012.082578","article-title":"Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein \u03b1 with 13\u00a0years difference at onset","volume":"98","author":"Debeljak","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1080","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3109\/10428194.2011.638718","article-title":"A novel CCAAT\/enhancer binding protein \u03b1 germline variant in a case of acute myeloid leukemia","volume":"53","author":"Gutman","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.leukres.2018.12.003","article-title":"Germline CEBPA mutations in Korean patients with acute myeloid leukemia","volume":"76","author":"Kim","year":"2019","journal-title":"Leuk Res"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/gcc.20734","article-title":"A family harboring a germ-line N-terminal C\/EBP\u03b1 mutation and development of acute myeloid leukemia with an additional somatic C-terminal C\/EBP\u03b1 mutation","volume":"49","author":"Nanri","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1095","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1182\/bloodadvances.2017004424","article-title":"Index case of acute myeloid leukemia in a family harboring a novel CEBPA germ line mutation","volume":"1","author":"Ram","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1100","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/leu.2008.294","article-title":"Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation","volume":"23","author":"Renneville","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1105","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.leu.2403788","article-title":"Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia","volume":"19","author":"Sellick","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1110","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/leu.2011.64","article-title":"Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein \u03b1 from hematopoietic cells in a family with AML","volume":"25","author":"Stelljes","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1115","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1182\/blood-2010-09-307280","article-title":"Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182\u00a0cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity","volume":"117","author":"Taskesen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1120","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2008.16.5563","article-title":"Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia","volume":"26","author":"Pabst","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41417-019-0133-7","article-title":"Companion gene mutations and their clinical significance in AML with double mutant CEBPA","volume":"27","author":"Zhang","year":"2020","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1130","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2019-129906","article-title":"DDX41\u00a0mutation in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, and acute myeloid leukemia","volume":"134","author":"Choi","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12185-019-02770-3","article-title":"Novel DDX41\u00a0variants in Thai patients with myeloid neoplasms","volume":"111","author":"Polprasert","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1140","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/leu.2016.124","article-title":"Germline heterozygous DDX41\u00a0variants in a subset of familial myelodysplasia and acute myeloid leukemia","volume":"30","author":"Cardoso","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1145","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ajh.25486","article-title":"DDX41\u00a0mutations in myeloid neoplasms are associated with male gender, TP53\u00a0mutations and high-risk disease","volume":"94","author":"Quesada","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1150","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.582213","article-title":"Next-generation sequencing of DDX41\u00a0in myeloid neoplasms leads to increased detection of germline alterations","volume":"10","author":"Bannon","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1155","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2009-09-245381","article-title":"Clonal analysis of TET2\u00a0and JAK2\u00a0mutations suggests that TET2\u00a0can be a late event in the progression of myeloproliferative neoplasms","volume":"115","author":"Schaub","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1160","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1080\/10428194.2021.1881508","article-title":"ATG2B\/GSKIP in de novo acute myeloid leukemia (AML): high prevalence of germline predisposition in French West Indies","volume":"62","author":"Pegliasco","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1165","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/leu.2013.363","article-title":"Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5\u00a0c.547G>A","volume":"28","author":"Auer","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1170","doi-asserted-by":"crossref","DOI":"10.17795\/zjrms-6670","article-title":"Variant study in the introns 1\u00a0and 2\u00a0of PAX5\u00a0gene in the patients with acute lymphoblastic leukemia disease","author":"Yazdanparast","year":"2016","journal-title":"Zahedan J Res Med Sci"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1175","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-019-0430-z","article-title":"PAX5\u00a0biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia","author":"Bastian","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.03.021","article-title":"Germline genetic IKZF1\u00a0variation and predisposition to childhood acute lymphoblastic leukemia","author":"Churchman","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1185","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJMoa1512234","article-title":"Loss of B cells in patients with heterozygous mutations in IKAROS","volume":"374","author":"Kuehn","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1182\/blood.2020007292","article-title":"Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies","volume":"137","author":"Kuehn","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1195","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/leu.2017.25","article-title":"Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia","volume":"31","author":"Yoshida","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1200","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1172\/JCI98164","article-title":"Dominant-negative IKZF1\u00a0mutations cause a T, B, and myeloid cell combined immunodeficiency","volume":"128","author":"Boutboul","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2016.09.029","article-title":"Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1\u00a0mutations","volume":"140","author":"Hoshino","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/gcc.22914","article-title":"Broad phenotypic spectrum of germ line 7p12.1\u00a0microdeletions encompassing the IKZF1\u00a0gene includes predisposition to acute lymphoblastic leukemia","volume":"60","author":"Pastorczak","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1215","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood-2012-08-452763","article-title":"GATA2\u00a0haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome","volume":"121","author":"Hsu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1220","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1182\/blood-2013-07-515528","article-title":"GATA2\u00a0deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity","volume":"123","author":"Spinner","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3324\/haematol.2013.090217","article-title":"Acquired ASXL1\u00a0mutations are common in patients with inherited GATA2\u00a0mutations and correlate with myeloid transformation","volume":"99","author":"West","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1230","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1235","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","article-title":"Exome sequencing identifies GATA-2\u00a0mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"118","author":"Dickinson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2014-06-580340","article-title":"GATA2\u00a0deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia","volume":"125","author":"Ganapathi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1245","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/pbc.26084","article-title":"Acute lymphoblastic leukemia in a patient with MonoMAC syndrome\/GATA2\u00a0haploinsufficiency","volume":"63","author":"Koegel","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1250","first-page":"1","article-title":"Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome","author":"Bortnick","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1255","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","article-title":"Mutations in GATA2\u00a0are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome","volume":"118","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1260","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00431-012-1715-7","article-title":"GATA-2\u00a0anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia","volume":"171","author":"Ishida","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1265","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2012-08-447367","article-title":"High frequency of GATA2\u00a0mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia","volume":"121","author":"Pasquet","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bjh.13317","article-title":"Haematopoietic and immune defects associated with GATA2\u00a0mutation","volume":"169","author":"Collin","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1275","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/blood-2011-08-374363","article-title":"Loss-of-function germline GATA2\u00a0mutations in patients with MDS\/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2\u00a0in the lymphatic vasculature","volume":"119","author":"Kazenwadel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1280","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ng.923","article-title":"Mutations in GATA2\u00a0cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)","volume":"43","author":"Ostergaard","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1285","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/bjh.16322","article-title":"In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9\u00a0mutation","volume":"188","author":"Hockings","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1290","first-page":"8","article-title":"The genomic landscape of pediatric myelodysplastic syndromes","author":"Schwartz","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1295","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/leu.2017.142","article-title":"Germline SAMD9\u00a0mutation in siblings with monosomy 7\u00a0and myelodysplastic syndrome","volume":"31","author":"Schwartz","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1300","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.09.002_bib1305","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3324\/haematol.2017.180778","article-title":"Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7","volume":"103","author":"Pastor","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2022.09.002_bib0655","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41375-018-0074-4","article-title":"SAMD9\u00a0and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies","volume":"32","author":"Davidsson","year":"2018","journal-title":"Leukemia"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455122003460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455122003460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:37:02Z","timestamp":1757792222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455122003460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0007455122003460"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2022.09.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conduite \u00e0 tenir devant une pr\u00e9disposition g\u00e9n\u00e9tique aux h\u00e9mopathies malignes chez un patient candidat \u00e0 l\u2019allogreffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques (CSH)\u00a0: recommandations de la SFGM-TC","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}